The Effects of Drugs on Protein Synthesis in the Nervous System

  • Doris H. Clouet


The effects which drugs have on protein synthesis in the nervous system of experimental animals fall into two general categories: (1) effects similar to those produced in other tissues by drugs which are well known as metabolic inhibitors or antibiotics, and (2) effects produced by drugs which have the nervous system as their probable site of action and which thus may be expected to have specific effects on metabolism in nervous tissue. In the present discussion the effects of metabolic inhibitors, antibiotics, and other, presumably nonspecific, drugs on protein synthesis or turnover in brain and nerve will be described briefly, with examples cited from the literature. Another class of drugs, those which affect a single enzyme system or classes of enzymes, which can be considered to be affecting a portion of the protein of the nervous system, will be discussed in terms of representative studies. Major attention will be given to studies from this laboratory on the responses in nervous tissue to the administration or addition of narcotic analgesic drugs.


Protein Synthesis Metabolic Inhibitor Specific Radioactivity Brain Protein Amino Acid Pool 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    D. H. Clouet, M. Ratner, and N. Williams, Biochem. Biophys. Acta 123, 142–150 (1966).PubMedGoogle Scholar
  2. 2.
    M. K. Campbell, H. R. Mahler, W. J. Moore, and S. Tewari, Biochemistry 5, 1174–1184 (1966).PubMedCrossRefGoogle Scholar
  3. 3.
    H. S. Bachelard, Biochem. J. 100, 131–137 (1966).PubMedGoogle Scholar
  4. 4.
    B. W. Agranoff, R. E. Davis, and J. J. Brink, Proc. Natl. Acad. Sci. U.S. 54, 788–793 (1965).CrossRefGoogle Scholar
  5. 5.
    S. H. Barondes and H. D. Cohen, Brain Res. 4, 44–48 (1967).PubMedCrossRefGoogle Scholar
  6. 6.
    S. H. Barondes and H. D. Cohen, Proc. Natl. Acad. Sci. U.S. 58, 157–164 (1967).CrossRefGoogle Scholar
  7. 7.
    L. B. Flexner and J. B. Flexner, Proc. Natl. Acad. Sci. U.S. 55, 369–374 (1966).CrossRefGoogle Scholar
  8. 8.
    A. J. Dunn and A. Korner, Biochem. J. 100, 76P (1966).Google Scholar
  9. 9.
    A. Edström, J. Neurochem. 14, 239–243 (1967).PubMedCrossRefGoogle Scholar
  10. 10.
    M. T. Spoerlein and J. Strafani, Life Sci. 6, 1549–1564 (1967).CrossRefGoogle Scholar
  11. 11.
    S. Roberts and B. S. Morelos, J. Neurochem. 12, 373–387 (1965).PubMedCrossRefGoogle Scholar
  12. 12.
    F. Orrego and F. Lipmann, J. Biol. Chem. 242, 665–671 (1967).PubMedGoogle Scholar
  13. 13.
    K. F. Swaiman, W. B. Hosfield, and B. Lemieux, J. Neurochem. 15, 687–690 (1968).PubMedCrossRefGoogle Scholar
  14. 14.
    D. H. Clouet and H. Waelsch, J. Neurochem. 10, 51–63 (1963).CrossRefGoogle Scholar
  15. 15.
    D. H. Clouet and H. Waelsch, J. Neurochem. 8, 201–215 (1961).PubMedCrossRefGoogle Scholar
  16. 16.
    B. Holmstedt, M. Härkonen, G. Lundgren, and A. Sundwall, Biochem. Pharmacol. 16, 404–406 (1967).PubMedCrossRefGoogle Scholar
  17. 17.
    M. K. Gaitonde and D. Richter, Proc. Roy. Soc. (London) 145, 83–92 (1965).Google Scholar
  18. 18.
    R. S. Piha, S. S. Oja, and A. J. Usitalo, Ann. Med. Exp. Biol. Fenn 40, Suppl. 5, 1–28 (1962).Google Scholar
  19. 19.
    A. J. Glasky, Fed. Proc. 22, 272 (1963).Google Scholar
  20. 20.
    L. Shuster and R. V. Hannan, J. Biol. Chem. 239, 3401–3406 (1964).PubMedGoogle Scholar
  21. 21.
    H. Nybäck and G. Sedvall, J. Pharmacol. Exp. Ther. 162, 294–301 (1968).PubMedGoogle Scholar
  22. 22.
    R. J. Wurtman, J. Axelrod, and F. Anton-Tay, J. Pharmacol. Exp. Ther. 161, 367–372 (1968).PubMedGoogle Scholar
  23. 23.
    P. Kraus and Z. Simane, Experientia 23, 90–91 (1967).PubMedCrossRefGoogle Scholar
  24. 24.
    D. H. Clouet and M. Ratner, Brain Res. 4, 33–43 (1967).PubMedCrossRefGoogle Scholar
  25. 25.
    D. H. Clouet and A. Neidle, unpublished experiments.Google Scholar
  26. 26.
    D. H. Clouet and M. Ratner, J. Neurochem. 15, 17–23 (1968).PubMedCrossRefGoogle Scholar
  27. 27.
    M. Cohen, A. S. Keats, W. Krivoy, and G. Ungar, Proc. Soc. Exp. Biol. Med. 119, 381–384 (1965).PubMedGoogle Scholar
  28. 28.
    A. A. Smith, M. Karmin, and J. Gavitt, Biochem. Pharmacol. 15, 1877–1879 (1966).CrossRefGoogle Scholar
  29. 29.
    I. Yamamoto, R. Inoki, Y. Tamari, and K. Iwatsubo, Japan. J. Pharmacol. 17, 140–146 (1967).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1970

Authors and Affiliations

  • Doris H. Clouet
    • 1
  1. 1.New York State Research Institute for Neurochemistry and Drug AddictionNew YorkUSA

Personalised recommendations